Virginia Wealth Management Group Inc. Acquires New Position in Danaher Corporation $DHR

Virginia Wealth Management Group Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 56,349 shares of the conglomerate’s stock, valued at approximately $12,484,000. Danaher makes up about 5.4% of Virginia Wealth Management Group Inc.’s portfolio, making the stock its 2nd biggest position.

A number of other large investors have also bought and sold shares of the stock. Marquette Asset Management LLC boosted its holdings in Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares in the last quarter. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher during the second quarter valued at approximately $25,000. Main Street Group LTD bought a new stake in shares of Danaher during the first quarter valued at approximately $25,000. Field & Main Bank acquired a new position in shares of Danaher during the second quarter worth approximately $29,000. Finally, Evolution Wealth Management Inc. raised its position in shares of Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 104 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Potential earnings beat: Zacks says Danaher has a strong earnings-surprise history and currently shows the two indicators—earnings estimate revisions and an Earnings ESP reading—that can signal another quarterly beat. Analysts expect earnings growth in the upcoming report. Will Danaher Beat Estimates Again in Its Next Earnings Report?
• Positive Sentiment: NVIDIA collaboration supports AI strategy: Danaher announced a partnership with NVIDIA to combine its scientific instruments, laboratory automation, workflow software and domain expertise with NVIDIA’s accelerated computing and AI technologies. The goal is to advance autonomous science and speed up scientific discovery, creating a potentially important long-term growth opportunity in life-science research. Danaher Collaborates with NVIDIA to Advance Autonomous Science
• Positive Sentiment: Autonomous laboratory plans: Danaher plans to launch its first AI-powered autonomous laboratory, with commercial-scale operations expected in early 2027. The initiative could improve laboratory productivity and strengthen Danaher’s positioning in AI-enabled drug discovery, though meaningful revenue benefits are likely longer term. How to Invest in AI Drug Discovery
• Neutral Sentiment: Analyst support: Morgan Stanley maintained its $240 price target for DHR, indicating continued confidence in the company’s outlook but no new change in the valuation view. Morgan Stanley Keeps $240 Target for Danaher Stock
• Neutral Sentiment: Board expansion: Danaher expanded its board to 13 members and appointed new directors, a governance development with limited immediate earnings impact. Danaher Enhances Board With New Director Appointments

Wall Street Analyst Weigh In

Several analysts recently issued reports on DHR shares. Royal Bank Of Canada lifted their price target on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Morgan Stanley lifted their price objective on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday. The Goldman Sachs Group boosted their target price on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Finally, Evercore restated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $235.41.

Danaher Stock Up 0.8%

NYSE:DHR traded up $1.81 during trading hours on Wednesday, hitting $224.65. 3,595,884 shares of the company traded hands, compared to its average volume of 4,457,645. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market cap of $157.93 billion, a PE ratio of 39.90, a PEG ratio of 2.78 and a beta of 0.76. The firm’s 50-day simple moving average is $212.92 and its 200-day simple moving average is $195.39. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the business posted $0.77 EPS. The business’s revenue was up 5.5% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 28.42%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.